Finally, clinical trials have also assessed the efficacy of long-term albumin administration in patients with cirrhosis and ascites, opening up new perspectives for its use in decompensated cirrhosis [7••, 8•, 9•]. The gene discussed is ALB; the disease is Cirrhosis.